CCL2 and prostate carcinoma: Clinically elevated plasma concentrations of EV-associated markers of inflammation (CRP, MCP-1, IFNα2, IL-8, IL-12p70, and MCP-1) have been observed in prostate cancer patients with symptomatic fatigue [116].